Dr. Radhika Tripuraneni

Dr. Radhika Tripuraneni

atViridian Therapeutics, Inc.\DE· In the 2025 proxy

Pay in FY2025Viridian Therapeutics, Inc.\DE stock +62.3% the same year

Dr. Radhika Tripuraneni was paid $4.1M in FY2025 (Dec). Viridian Therapeutics, Inc.\DE stock rose 62.3% that year.

Pay$100 in the stock at the end of FY24 → $162
Pay is from the Summary Compensation Table of each Viridian Therapeutics, Inc.\DE proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Viridian Therapeutics, Inc.\DEPublic company · 1 yr
    • 2025 – Present · 1 yrStock in role +26%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?